- Home
- LOBO vs TTNP Comparison
LOBO vs TTNP Comparison
Compare LOBO & TTNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LOBO
- TTNP
- Stock Information
- Founded
- LOBO 2014
- TTNP 1991
- Country
- LOBO China
- TTNP United States
- Employees
- LOBO N/A
- TTNP N/A
- Industry
- LOBO
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LOBO
- TTNP Health Care
- Exchange
- LOBO NYSE
- TTNP Nasdaq
- Market Cap
- LOBO 6.4M
- TTNP 5.9M
- IPO Year
- LOBO 2024
- TTNP 1996
- Fundamental
- Price
- LOBO $0.45
- TTNP $4.07
- Analyst Decision
- LOBO
- TTNP
- Analyst Count
- LOBO 0
- TTNP 0
- Target Price
- LOBO N/A
- TTNP N/A
- AVG Volume (30 Days)
- LOBO 879.2K
- TTNP 16.5K
- Earning Date
- LOBO 04-29-2025
- TTNP 08-14-2025
- Dividend Yield
- LOBO N/A
- TTNP N/A
- EPS Growth
- LOBO N/A
- TTNP N/A
- EPS
- LOBO N/A
- TTNP N/A
- Revenue
- LOBO $21,188,606.00
- TTNP N/A
- Revenue This Year
- LOBO $77.34
- TTNP N/A
- Revenue Next Year
- LOBO N/A
- TTNP N/A
- P/E Ratio
- LOBO N/A
- TTNP N/A
- Revenue Growth
- LOBO 36.92
- TTNP N/A
- 52 Week Low
- LOBO $0.42
- TTNP $3.03
- 52 Week High
- LOBO $3.52
- TTNP $14.80
- Technical
- Relative Strength Index (RSI)
- LOBO N/A
- TTNP 41.41
- Support Level
- LOBO N/A
- TTNP $4.62
- Resistance Level
- LOBO N/A
- TTNP $5.35
- Average True Range (ATR)
- LOBO 0.00
- TTNP 0.40
- MACD
- LOBO 0.00
- TTNP 0.01
- Stochastic Oscillator
- LOBO 0.00
- TTNP 16.34
About LOBO LOBO EV TECHNOLOGIES LTD
Lobo EV Technologies Ltd is an electric vehicle manufacturer and seller company. It designs, develops, manufactures, and sells e-bicycles, e-mopeds, e-tricycles, and electric off-highway four-wheeled shuttles such as golf carts and mobility scooters for the elderly and disabled persons, also provides automobile information and entertainment software development and design services to customers. The company operates in two operating segments: the Electric vehicles and accessories sales segment, which generates key revenue, and the software royalties and development and design services segment. It generates all of its revenue within the People's Republic of China.
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.